Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

JKB-122 is effective, alone or in combination with prednisolone in Con A-induced hepatitis.

Hsu MC, Liu SH, Wang CW, Hu NY, Wu ESC, Shih YC, Chiu PJS.

Eur J Pharmacol. 2017 Oct 5;812:113-120. doi: 10.1016/j.ejphar.2017.07.012. Epub 2017 Jul 8.

PMID:
28694068
2.

Determinants of influenza vaccination among young Taiwanese children.

Chen CH, Chiu PJ, Chih YC, Yeh GL.

Vaccine. 2015 Apr 15;33(16):1993-8. doi: 10.1016/j.vaccine.2015.01.032. Epub 2015 Jan 19.

PMID:
25613722
3.

Effectiveness of the influenza vaccination program for the elderly in Taiwan.

Chiu PJ, Chen CH, Chih YC.

Vaccine. 2013 Jan 11;31(4):632-8. doi: 10.1016/j.vaccine.2012.11.055. Epub 2012 Dec 1.

PMID:
23212027
4.

Synthesis and solid-state NMR characterization of cubic mesoporous silica SBA-1 functionalized with sulfonic acid groups.

Tsai HH, Chiu PJ, Jheng GL, Ting CC, Pan YC, Kao HM.

J Colloid Interface Sci. 2011 Jul 1;359(1):86-94. doi: 10.1016/j.jcis.2011.03.072. Epub 2011 Mar 27.

PMID:
21507414
5.

Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels.

Chiu PJ, Marcoe KF, Bounds SE, Lin CH, Feng JJ, Lin A, Cheng FC, Crumb WJ, Mitchell R.

J Pharmacol Sci. 2004 Jul;95(3):311-9.

6.

Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats.

Chintala MS, Chiu PJ, Bernadino V, Tetzloff GG, Tedesco R, Sabin C, Watkins RW, Sybertz EJ.

Eur J Pharmacol. 1998 May 22;349(2-3):237-43.

PMID:
9671103
7.

Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigs.

Chiu PJ, Vemulapalli S, Chintala M, Kurowski S, Tetzloff GG, Brown AD, Sybertz EJ.

Naunyn Schmiedebergs Arch Pharmacol. 1997 Apr;355(4):463-9.

PMID:
9109362
8.

Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs.

Chiu PJ, Tetzloff GG, Foster C, Chintala M, Sybertz EJ.

Eur J Pharmacol. 1997 Feb 19;321(1):129-35.

PMID:
9083795
9.

In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery.

Vemulapalli S, Chiu PJ, Kurowski S, Brown A, Hartman BD, Leach MW.

Pharmacology. 1996 Apr;52(4):235-42.

PMID:
8841086
10.

Interleukin-10 pharmacokinetics in intact and nephrectomized mice.

Chiu PJ, Radwanski E, Tetiloff G, Monge A, Swanson SJ.

Eur Cytokine Netw. 1996 Jan-Mar;7(1):67-9.

PMID:
8704097
11.
12.

Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats.

Chintala MS, Bernardino V, Chiu PJ.

J Pharmacol Exp Ther. 1994 Dec;271(3):1203-8.

PMID:
7996427
13.

In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit.

Sandoli D, Chiu PJ, Chintala M, Dionisotti S, Ongini E.

Eur J Pharmacol. 1994 Jun 23;259(1):43-9.

PMID:
7957592
14.

Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats.

Vemulapalli S, Chiu PJ, Griscti K, Brown A, Kurowski S, Sybertz EJ.

Eur J Pharmacol. 1994 May 12;257(1-2):95-102.

PMID:
8082712
15.

Attenuation of ischemic acute renal failure by phosphoramidon in rats.

Vemulapalli S, Chiu PJ, Chintala M, Bernardino V.

Pharmacology. 1993 Sep;47(3):188-93.

PMID:
8415869
16.

Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats.

Chintala MS, Chiu PJ, Vemulapalli S, Watkins RW, Sybertz EJ.

Naunyn Schmiedebergs Arch Pharmacol. 1993 Sep;348(3):305-10.

PMID:
8232607
17.

Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor.

Watkins RW, Vemulapalli S, Chiu PJ, Foster C, Smith EM, Neustadt B, Haslanger M, Sybertz EJ.

Am J Hypertens. 1993 May;6(5 Pt 1):357-68.

PMID:
8512660
18.

Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats.

Vemulapalli S, Watkins RW, Brown A, Cook J, Bernardino V, Chiu PJ.

Life Sci. 1993;53(10):783-93.

PMID:
8355566
19.

Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs.

Vemulapalli S, Rivelli M, Chiu PJ, del Prado M, Hey JA.

J Pharmacol Exp Ther. 1992 Sep;262(3):1062-9.

PMID:
1527713
20.

Sympathoadrenal stimulation, not endothelin, plays a role in acute pressor response to cyclosporine in anesthetized rats.

Chiu PJ, Vemulapalli S, Sabin C, Rivelli M, Bernardino V, Sybertz EJ.

J Pharmacol Exp Ther. 1992 Jun;261(3):994-9.

PMID:
1602404
21.

Modulation of circulating endothelin levels in hypertension and endotoxemia in rats.

Vemulapalli S, Chiu PJ, Rivelli M, Foster CJ, Sybertz EJ.

J Cardiovasc Pharmacol. 1991 Dec;18(6):895-903.

PMID:
1725904
22.

Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.

Sybertz EJ Jr, Chiu PJ, Watkins RW, Vemulapalli S.

Can J Physiol Pharmacol. 1991 Oct;69(10):1628-35.

PMID:
1838029
23.

Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats.

Chiu PJ, Tetzloff G, Romano MT, Foster CJ, Sybertz EJ.

Am J Physiol. 1991 Jan;260(1 Pt 2):R208-16.

PMID:
1847022
24.
25.

The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats.

Vemulapalli S, Chiu PJ, Brown A, Griscti K, Sybertz EJ.

Life Sci. 1991;49(5):383-91. Erratum in: Life Sci 1992;50(12):899.

PMID:
1649942
26.

Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation.

Sybertz EJ Jr, Chiu PJ, Watkins RW, Vemulapalli S.

J Hypertens Suppl. 1990 Dec;8(7):S161-7.

PMID:
2151333
27.

Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.

Sybertz EJ, Chiu PJ, Vemulapalli S, Watkins R, Haslanger MF.

Hypertension. 1990 Feb;15(2):152-61.

PMID:
2154404
28.

Antiulcer agents. 4. Conformational considerations and the antiulcer activity of substituted imidazo[1,2-a]pyridines and related analogues.

Kaminski JJ, Puchalski C, Solomon DM, Rizvi RK, Conn DJ, Elliott AJ, Lovey RG, Guzik H, Chiu PJ, Long JF, et al.

J Med Chem. 1989 Aug;32(8):1686-700.

PMID:
2754693
29.

SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.

Sybertz EJ, Chiu PJ, Vemulapalli S, Pitts B, Foster CJ, Watkins RW, Barnett A, Haslanger MF.

J Pharmacol Exp Ther. 1989 Aug;250(2):624-31.

PMID:
2547941
30.

Antiinflammatory activity of a series of substituted 2,3-dihydro-6-hydroxypyrimido[2,1-f]purine-4,8(1H,9H)-diones.

Kaminski JJ, Solomon DM, Conn DJ, Wong SC, Chiu PJ, Massa T, Siegel MI, Watnick AS.

J Med Chem. 1989 May;32(5):1118-27.

PMID:
2496230
31.

Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle.

Chiu PJ, Tetzloff G, Ahn HS, Sybertz EJ.

Eur J Pharmacol. 1988 Oct 18;155(3):229-37.

PMID:
3234486
32.

Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.

Chiu PJ, Barnett A, Siegel M, Brown AD, Gerhart C.

J Pharmacol Exp Ther. 1988 Aug;246(2):578-84.

PMID:
3404447
33.

Phorbol 12,13-dibutyrate, an activator of protein kinase C, stimulates both contraction and Ca2+ fluxes in dog saphenous vein.

Chiu PJ, Tetzloff G, Chatterjee M, Sybertz EJ.

Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):114-20.

PMID:
3185741
34.

Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and 45Ca-fluxes in the rabbit aorta.

Chiu PJ, Tetzloff G, Ahn HS, Sybertz EJ.

Am J Hypertens. 1988 Jul;1(3 Pt 1):262-8.

PMID:
2455529
35.

Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines.

Smith EM, Swiss GF, Neustadt BR, Gold EH, Sommer JA, Brown AD, Chiu PJ, Moran R, Sybertz EJ, Baum T.

J Med Chem. 1988 Apr;31(4):875-85.

PMID:
2832605
36.

Effect of amiloride on regulatory mechanisms of vascular smooth muscle contraction.

Chatterjee M, Chiu PJ, Doll RJ, Sybertz EJ.

Biochem Pharmacol. 1988 Mar 1;37(5):813-8.

PMID:
2449893
37.

The responses of atrial natriuretic factor concentrations to acute volume changes in conscious rats.

Chiu PJ, Vemulapalli S, Policelli M, Kifor I, Sybertz EJ, Dzau VJ.

Life Sci. 1987 Nov 23;41(21):2339-47.

PMID:
2960866
38.

Antiulcer agents. 3. Structure-activity-toxicity relationships of substituted imidazo[1,2-a]pyridines and a related imidazo[1,2-a]pyrazine.

Kaminski JJ, Perkins DG, Frantz JD, Solomon DM, Elliott AJ, Chiu PJ, Long JF.

J Med Chem. 1987 Nov;30(11):2047-51.

PMID:
3669012
39.

Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.

Parmegiani RM, Loebenberg D, Antonacci B, Yarosh-Tomaine T, Scupp R, Wright JJ, Chiu PJ, Miller GH.

Antimicrob Agents Chemother. 1987 Nov;31(11):1756-60.

40.

Comparative renal effects of calcium channel blockers in conscious spontaneously hypertensive rats.

Vemulapalli S, Chiu PJ, Sybertz EJ.

Arch Int Pharmacodyn Ther. 1987 Jun;287(2):309-22.

PMID:
2888444
41.
42.

Phorbol dibutyrate contractions in rabbit aorta: calcium dependence and sensitivity to nitrovasodilators and 8-BR-cyclic GMP.

Sybertz EJ, Desiderio DM, Tetzloff G, Chiu PJ.

J Pharmacol Exp Ther. 1986 Oct;239(1):78-83.

PMID:
3093673
43.

A post-calcium site of action for HA1004, a novel vasculorelaxant.

Chiu PJ, Tetzloff G, Sybertz EJ.

Life Sci. 1986 Jul 21;39(3):255-61.

PMID:
3736325
44.

Antiinflammatory activity of substituted 6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-triones. Atypical nonsteroidal antiinflammatory agents.

Blythin DJ, Kaminski JJ, Domalski MS, Spitler J, Solomon DM, Conn DJ, Wong SC, Verbiar LL, Bober LA, Chiu PJ, et al.

J Med Chem. 1986 Jun;29(6):1099-113.

PMID:
3086558
45.

The effects of atriopeptin II on calcium fluxes in rabbit aorta.

Chiu PJ, Tetzloff G, Sybertz EJ.

Eur J Pharmacol. 1986 May 27;124(3):277-84.

PMID:
2426119
46.

AGEPC, a vasodilator phospholipid with profound circulatory actions.

Sybertz EJ, Watkins RW, Vemulapalli S, Baum T, Chiu PJ, Barnett A.

Prog Clin Biol Res. 1986;219:133-56. Review.

PMID:
3538024
47.
48.
49.

Gastric cytoprotective properties of SCH 32651, a novel antiulcer agent.

Chiu PJ, Barnett A, Gerhart C, Policelli M, Kaminski J.

Arch Int Pharmacodyn Ther. 1984 Jul;270(1):128-40.

PMID:
6548621
50.

Cardiovascular and renal action of platelet-activating factor in anesthetized dogs.

Vemulapalli S, Chiu PJ, Barnett A.

Hypertension. 1984 Jul-Aug;6(4):489-93.

PMID:
6378787

Supplemental Content

Support Center